Megasorb CoQ-10 100 mg

Name: Megasorb CoQ-10 100 mg
Brand: Solgar

BrandSolgar→Non-Nutrient/Non-Botanical Softgel Capsule 7 ingredients 1 banned DSLD #201089

Net contents: 90 Softgel(s)

Target: Adults and Children 4 years and above

DSLD entry: 2019-04-25

Brand marketing claims reviewed — Claims: quality superlatives. 3 claims assessed against named sources. See Solgar claim review →

2 Ingredients (7)

IngredientGroupSafety

Megasorb Coenzyme Q-10Coenzyme Q10Generally Safe

Rice Bran OilRice Oil—

GelatinGelatin—

Vegetable GlycerinGlycerol—

Soy Lecithinlecithin—

PaprikaCapsicum—

Titanium Dioxide colorTitanium DioxideBanned in ≥1 country

Ingredient amounts require the full DSLD label. View full label at NIH DSLD →

⛔ Contains an ingredient banned in ≥1 country

Titanium Dioxide 🇫🇷 🇪🇺 — France banned TiO₂ in food from January 2020, first EU country.

3 Safety cross-reference

Coenzyme Q10 — Generally Safe

⚠ May reduce warfarin efficacy

⚠ Mild GI effects

Titanium Dioxide — Banned in ≥1 country

⚠ EFSA: can no longer be considered safe as food additive (2021)

⚠ Genotoxicity concern (nanoparticles)

4 Label claims

• All Other

• Structure/Function

5 Data source

DSLD ID201089

Full labelView at NIH DSLD →

SourceOffice of Dietary Supplements, NIH

Market statusOn market

Entry date2019-04-25

6 More from Solgar

View Solgar Safety Scorecard → 668 products

100% Pure Shark Cartilage 100% Pure Shark Cartilage 1300 mg Omega 3-6-9 Fish, Flax, Borage 5-HTP 100 mg 5-HTP 100მგ 90 კაფსულა სოლგარი - Solgar ABC Dophilus Powder

7 Cite this page

Vancouver

Pkhakadze G. Megasorb CoQ-10 100 mg — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Oct 18]. Available from: https://supplement.ge/products/megasorb-coq-10-100-mg-201089/

CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.

Analyzed by SupplementIndex

PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD

Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG